SAB Biotherapeutics Inc. (SABSW)
0.02
-0.01 (-23.08%)
At close: Apr 16, 2025, 3:54 PM
13F Institute Ownership
Total Institutes of 10 in SAB Biotherapeutics expanded their positions with an increase of 0 investors compared to the previous quarter. An additional 259.1K shares, as total invested capital grew by $43.99K with ownership percentage increasing from 6.70% to 9.50%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Lmr Partners Llp | 5.83% | 539.59K | +100.00% | 40.63K | < 0.01% |
| Morgan Stanley | 1.58% | 146.44K | +0.00% | 11.03K | < 0.01% |
| Yakira Capital Management, Inc... | 1.01% | 93.23K | -14.06% | 7.02K | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.